Correlation Between Telomir Pharmaceuticals, and Neurocrine Biosciences

Can any of the company-specific risk be diversified away by investing in both Telomir Pharmaceuticals, and Neurocrine Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Telomir Pharmaceuticals, and Neurocrine Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Telomir Pharmaceuticals, Common and Neurocrine Biosciences, you can compare the effects of market volatilities on Telomir Pharmaceuticals, and Neurocrine Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Telomir Pharmaceuticals, with a short position of Neurocrine Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Telomir Pharmaceuticals, and Neurocrine Biosciences.

Diversification Opportunities for Telomir Pharmaceuticals, and Neurocrine Biosciences

-0.23

Correlation Coefficient

Telomir Pharmaceuticals,  Neurocrine Biosciences

Very good diversification

The 3 months correlation between Telomir and Neurocrine is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Telomir Pharmaceuticals, Commo and Neurocrine Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurocrine Biosciences and Telomir Pharmaceuticals, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Telomir Pharmaceuticals, Common are associated (or correlated) with Neurocrine Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurocrine Biosciences has no effect on the direction of Telomir Pharmaceuticals, i.e., Telomir Pharmaceuticals, and Neurocrine Biosciences go up and down completely randomly.

Pair Corralation between Telomir Pharmaceuticals, and Neurocrine Biosciences

Given the investment horizon of 90 days Telomir Pharmaceuticals, Common is expected to under-perform the Neurocrine Biosciences. In addition to that, Telomir Pharmaceuticals, is 4.44 times more volatile than Neurocrine Biosciences. It trades about -0.03 of its total potential returns per unit of risk. Neurocrine Biosciences is currently generating about 0.12 per unit of volatility. If you would invest  12,046  in Neurocrine Biosciences on September 19, 2024 and sell it today you would earn a total of  1,623  from holding Neurocrine Biosciences or generate 13.47% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Telomir Pharmaceuticals, Commo  vs.  Neurocrine Biosciences

Telomir Pharmaceuticals,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Telomir Pharmaceuticals, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Neurocrine Biosciences

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Neurocrine Biosciences are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent forward indicators, Neurocrine Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Telomir Pharmaceuticals, and Neurocrine Biosciences

The main advantage of trading using opposite Telomir Pharmaceuticals, and Neurocrine Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Telomir Pharmaceuticals, position performs unexpectedly, Neurocrine Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurocrine Biosciences will offset losses from the drop in Neurocrine Biosciences' long position.

The idea behind Telomir Pharmaceuticals, Common and Neurocrine Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.